Sign Up to like & get
recommendations!
2
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.9100
Abstract: 9100Background: Tyrosine Kinase inhibitors (TKI) have changed the treatment paradigm in patients with stage IV adenocarcinoma of the lung (AdenoCa) harboring epidermal growth factor receptor (EGFR)...
read more here.
Keywords:
adenocarcinoma lung;
reporting stage;
stage adenocarcinoma;
egfr reporting ... See more keywords